Nefiracetam
Nefiracetam (DM9384), a modulator of GABAergic, cholinergic, and monoaminergic systems, is under Phase 2 clinical investigation. It has demonstrated efficacy in preclinical models, such as suppressing Ro 5-4864-induced convulsions in vivo, supporting research in neuroscience and cognitive disorders.
Product Specifications
CAS Number
77191-36-7
Product Name Alternative
DZL 221, DZL221, DZL-221, DM 9384, DM9384, DM-9384, GABAReceptor, Gamma-aminobutyric acid Receptor, GABAR, GABA Receptor, Inhibitor, Nefiracetam, inhibit, γ-Aminobutyric acid Receptor
Field of Research
Epigenetics & Chromatin, Metabolism Research, Neuroscience, Pharmacology & Drug Discovery, Signal Transduction
Purity
90.88% (May vary between batches)
Solubility
DMSO:70 mg/mL (284.21 mM) ; Ethanol:24.6 mg/mL (99.88 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (8.12 mM)
Smiles
N (C (CN1C (=O) CCC1) =O) C2=C (C) C=CC=C2C
Molecular Formula
C14H18N2O2
Molecular Weight
246.3
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
S0401-25D-ML750 100 µL
SCFR, NT (Mast/Stem Cell Growth Factor Receptor, Tyrosine-protein Kinase Kit, Proto-oncogene c-Kit, KIT, CD117) (MaxLight 750) discontinued
Sign In for Pricing
View Details 